Characterization of a novel murine Sost ER T2 Cre model targeting osteocytes

Delphine B. Maurel, Tsutomu Matsumoto, Julian A. Vallejo, Mark L. Johnson, Sarah L. Dallas, Yukiko Kitase, Marco Brotto, Michael J. Wacker, Marie A. Harris, Stephen E. Harris, Lynda Bonewald

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Transgenic mice are widely used to delete or overexpress genes in a cell specific manner to advance knowledge of bone biology, function and disease. While numerous Cre models exist to target gene recombination in osteoblasts and osteoclasts, few target osteocytes specifically, particularly mature osteocytes. Our goal was to create a spatial and temporal conditional Cre model using tamoxifen to induce Cre activity in mature osteocytes using a Bac construct containing the 5’ and 3’ regions of the Sost gene (Sost ER T2 Cre). Four founder lines were crossed with the Ai9 Cre reporter mice. One founder line showed high and specific activity in mature osteocytes. Bones and organs were imaged and fluorescent signal quantitated. While no activity was observed in 2 day old pups, by 2 months of age some osteocytes were positive as osteocyte Cre activity became spontaneous or ‘leaky’ with age. The percentage of positive osteocytes increased following tamoxifen injection, especially in males, with 43% to 95% positive cells compared to 19% to 32% in females. No signal was observed in any bone surface cell, bone marrow, nor in muscle with or without tamoxifen injection. No spontaneous signal was observed in any other organ. However, with tamoxifen injection, a few positive cells were observed in kidney, eye, lung, heart and brain. All other organs, 28 in total, were negative with tamoxifen injection. However, with age, a muscle phenotype was apparent in the Sost-ER T2 Cre mice. Therefore, although this mouse model may be useful for targeting gene deletion or expression to mature osteocytes, the muscle phenotype may restrict the use of this model to specific applications and should be considered when interpreting data.

Original languageEnglish (US)
Article number6
JournalBone Research
Volume7
Issue number1
DOIs
StatePublished - Dec 1 2019

Fingerprint

Osteocytes
Tamoxifen
Injections
Bone and Bones
Muscles
Genes
Phenotype
Gene Deletion
Osteoclasts
Osteoblasts
Bone Marrow Cells
Transgenic Mice
Genetic Recombination
Kidney
Gene Expression
Lung
Brain

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Histology
  • Physiology

Cite this

Maurel, D. B., Matsumoto, T., Vallejo, J. A., Johnson, M. L., Dallas, S. L., Kitase, Y., ... Bonewald, L. (2019). Characterization of a novel murine Sost ER T2 Cre model targeting osteocytes Bone Research, 7(1), [6]. https://doi.org/10.1038/s41413-018-0037-4

Characterization of a novel murine Sost ER T2 Cre model targeting osteocytes . / Maurel, Delphine B.; Matsumoto, Tsutomu; Vallejo, Julian A.; Johnson, Mark L.; Dallas, Sarah L.; Kitase, Yukiko; Brotto, Marco; Wacker, Michael J.; Harris, Marie A.; Harris, Stephen E.; Bonewald, Lynda.

In: Bone Research, Vol. 7, No. 1, 6, 01.12.2019.

Research output: Contribution to journalArticle

Maurel, DB, Matsumoto, T, Vallejo, JA, Johnson, ML, Dallas, SL, Kitase, Y, Brotto, M, Wacker, MJ, Harris, MA, Harris, SE & Bonewald, L 2019, ' Characterization of a novel murine Sost ER T2 Cre model targeting osteocytes ', Bone Research, vol. 7, no. 1, 6. https://doi.org/10.1038/s41413-018-0037-4
Maurel DB, Matsumoto T, Vallejo JA, Johnson ML, Dallas SL, Kitase Y et al. Characterization of a novel murine Sost ER T2 Cre model targeting osteocytes Bone Research. 2019 Dec 1;7(1). 6. https://doi.org/10.1038/s41413-018-0037-4
Maurel, Delphine B. ; Matsumoto, Tsutomu ; Vallejo, Julian A. ; Johnson, Mark L. ; Dallas, Sarah L. ; Kitase, Yukiko ; Brotto, Marco ; Wacker, Michael J. ; Harris, Marie A. ; Harris, Stephen E. ; Bonewald, Lynda. / Characterization of a novel murine Sost ER T2 Cre model targeting osteocytes In: Bone Research. 2019 ; Vol. 7, No. 1.
@article{a2310a9dba8d409aad3f17da93c72954,
title = "Characterization of a novel murine Sost ER T2 Cre model targeting osteocytes",
abstract = "Transgenic mice are widely used to delete or overexpress genes in a cell specific manner to advance knowledge of bone biology, function and disease. While numerous Cre models exist to target gene recombination in osteoblasts and osteoclasts, few target osteocytes specifically, particularly mature osteocytes. Our goal was to create a spatial and temporal conditional Cre model using tamoxifen to induce Cre activity in mature osteocytes using a Bac construct containing the 5’ and 3’ regions of the Sost gene (Sost ER T2 Cre). Four founder lines were crossed with the Ai9 Cre reporter mice. One founder line showed high and specific activity in mature osteocytes. Bones and organs were imaged and fluorescent signal quantitated. While no activity was observed in 2 day old pups, by 2 months of age some osteocytes were positive as osteocyte Cre activity became spontaneous or ‘leaky’ with age. The percentage of positive osteocytes increased following tamoxifen injection, especially in males, with 43{\%} to 95{\%} positive cells compared to 19{\%} to 32{\%} in females. No signal was observed in any bone surface cell, bone marrow, nor in muscle with or without tamoxifen injection. No spontaneous signal was observed in any other organ. However, with tamoxifen injection, a few positive cells were observed in kidney, eye, lung, heart and brain. All other organs, 28 in total, were negative with tamoxifen injection. However, with age, a muscle phenotype was apparent in the Sost-ER T2 Cre mice. Therefore, although this mouse model may be useful for targeting gene deletion or expression to mature osteocytes, the muscle phenotype may restrict the use of this model to specific applications and should be considered when interpreting data.",
author = "Maurel, {Delphine B.} and Tsutomu Matsumoto and Vallejo, {Julian A.} and Johnson, {Mark L.} and Dallas, {Sarah L.} and Yukiko Kitase and Marco Brotto and Wacker, {Michael J.} and Harris, {Marie A.} and Harris, {Stephen E.} and Lynda Bonewald",
year = "2019",
month = "12",
day = "1",
doi = "10.1038/s41413-018-0037-4",
language = "English (US)",
volume = "7",
journal = "Bone Research",
issn = "2095-4700",
publisher = "Nature Publishing Group",
number = "1",

}

TY - JOUR

T1 - Characterization of a novel murine Sost ER T2 Cre model targeting osteocytes

AU - Maurel, Delphine B.

AU - Matsumoto, Tsutomu

AU - Vallejo, Julian A.

AU - Johnson, Mark L.

AU - Dallas, Sarah L.

AU - Kitase, Yukiko

AU - Brotto, Marco

AU - Wacker, Michael J.

AU - Harris, Marie A.

AU - Harris, Stephen E.

AU - Bonewald, Lynda

PY - 2019/12/1

Y1 - 2019/12/1

N2 - Transgenic mice are widely used to delete or overexpress genes in a cell specific manner to advance knowledge of bone biology, function and disease. While numerous Cre models exist to target gene recombination in osteoblasts and osteoclasts, few target osteocytes specifically, particularly mature osteocytes. Our goal was to create a spatial and temporal conditional Cre model using tamoxifen to induce Cre activity in mature osteocytes using a Bac construct containing the 5’ and 3’ regions of the Sost gene (Sost ER T2 Cre). Four founder lines were crossed with the Ai9 Cre reporter mice. One founder line showed high and specific activity in mature osteocytes. Bones and organs were imaged and fluorescent signal quantitated. While no activity was observed in 2 day old pups, by 2 months of age some osteocytes were positive as osteocyte Cre activity became spontaneous or ‘leaky’ with age. The percentage of positive osteocytes increased following tamoxifen injection, especially in males, with 43% to 95% positive cells compared to 19% to 32% in females. No signal was observed in any bone surface cell, bone marrow, nor in muscle with or without tamoxifen injection. No spontaneous signal was observed in any other organ. However, with tamoxifen injection, a few positive cells were observed in kidney, eye, lung, heart and brain. All other organs, 28 in total, were negative with tamoxifen injection. However, with age, a muscle phenotype was apparent in the Sost-ER T2 Cre mice. Therefore, although this mouse model may be useful for targeting gene deletion or expression to mature osteocytes, the muscle phenotype may restrict the use of this model to specific applications and should be considered when interpreting data.

AB - Transgenic mice are widely used to delete or overexpress genes in a cell specific manner to advance knowledge of bone biology, function and disease. While numerous Cre models exist to target gene recombination in osteoblasts and osteoclasts, few target osteocytes specifically, particularly mature osteocytes. Our goal was to create a spatial and temporal conditional Cre model using tamoxifen to induce Cre activity in mature osteocytes using a Bac construct containing the 5’ and 3’ regions of the Sost gene (Sost ER T2 Cre). Four founder lines were crossed with the Ai9 Cre reporter mice. One founder line showed high and specific activity in mature osteocytes. Bones and organs were imaged and fluorescent signal quantitated. While no activity was observed in 2 day old pups, by 2 months of age some osteocytes were positive as osteocyte Cre activity became spontaneous or ‘leaky’ with age. The percentage of positive osteocytes increased following tamoxifen injection, especially in males, with 43% to 95% positive cells compared to 19% to 32% in females. No signal was observed in any bone surface cell, bone marrow, nor in muscle with or without tamoxifen injection. No spontaneous signal was observed in any other organ. However, with tamoxifen injection, a few positive cells were observed in kidney, eye, lung, heart and brain. All other organs, 28 in total, were negative with tamoxifen injection. However, with age, a muscle phenotype was apparent in the Sost-ER T2 Cre mice. Therefore, although this mouse model may be useful for targeting gene deletion or expression to mature osteocytes, the muscle phenotype may restrict the use of this model to specific applications and should be considered when interpreting data.

UR - http://www.scopus.com/inward/record.url?scp=85061842148&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85061842148&partnerID=8YFLogxK

U2 - 10.1038/s41413-018-0037-4

DO - 10.1038/s41413-018-0037-4

M3 - Article

AN - SCOPUS:85061842148

VL - 7

JO - Bone Research

JF - Bone Research

SN - 2095-4700

IS - 1

M1 - 6

ER -